Study: social performance scale may forecast schizophrenia treatment success
NCT ID NCT07445217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a scale that measures personal and social performance can predict symptom improvement in people with schizophrenia. Over 700 participants taking paliperidone were followed for 12 weeks. Results showed that those with better social functioning scores were more likely to see a meaningful drop in symptom severity. The study helps doctors understand which patients might benefit most from treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL OUTCOMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Calo Psychiatric Center
Pingtung City, 925, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?